Business
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value
Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, today highlighted the massive economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration's (FDA) newly issued draft guidance outlining evidentiary expectations for Premarket Tobacco Product Applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS).
About this update from Ispire Technology Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement","length":125,"tagName":"p"}]},{"val":[{"type":"text","content":"FDA guidance unlocks an estimated $50 billion total addressable market, allowing companies to lawfully transition the 70% illicit flavored vape market into a compliant ecosystem","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"Ispire's 40%-owned IKE Tech joint venture is positioned to generate $5 million to $20 million in annual recurring SaaS revenue per customer in the US","length":153,"tagName":"p"}]},{"val":[{"type":"text","content":"Based on conservative SaaS metrics, even a limited number of customers could potentially value the IKE joint venture in the hundreds of millions, dramatically increasing Ispire's book value","length":198,"tagName":"p"}]},{"val":[{"type":"text","content":"Ispire-backed IKE Tech was first to file component PMTA for continuous, blockchain-enabled age-gating technology","length":112,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":770,"olType":false},{"type":"text","content":"LOS ANGELES, March 16, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, today highlighted the massive economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration's (FDA) newly issued draft guidance outlining evidentiary expectations for Premarket Tobacco Product Applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS).","length":530,"tagName":"p"},{"type":"image","alt":"Ispire (PRNewsfoto/Ispire Technology Inc.)","displaySize":"","headline":null,"caption":"Ispire (PRNewsfoto/Ispire Technology Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":122,"url":"https://media.zenfs.com/en/prnewswire.com/50a59d11ef9a54b7e5010b383d1ccc81"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5xZqdvkrERQzLrf9YZgv1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/50a59d11ef9a54b7e5010b383d1ccc81","width":400,"height":122}},"href":"https://mma.prnewswire.com/media/2771569/Ispire_Technolog...